Dicerna Pharmaceuticals Inc (DRNA) Gross Profit Margin starting from the third quarter 2021 to third quarter 2020, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket
 


Dicerna Pharmaceuticals Inc   (NASDAQ: DRNA)


Dicerna Pharmaceuticals Inc 's Gross Profit Margin by quarter

Trends, Rankings, Statistics



DRNA Gross Profit Margin (Sep 30 2021)
Q3
(Jun 30 2021)
Q2
(Mar 31 2021)
Q1
(Dec 31 2020)
Q4
(Sep 30 2020)
Q3
Y / Y Revenue Change 28.81 %
Seq. Revenue Change 52.29 %
Revenue In Millions $62.95
Gross Profit Margin 0 %
Gross Profit Margin Total Ranking # 794
Gross Profit In Millions $0.00
Y / Y Gross Profit Change -
Seq. Gross Profit Change -


Commenting Third Quarter 2021 Gross Profit Margin



Observing third quarter 2021 results within Major Pharmaceutical Preparations industry 143 other companies have achieved higher Gross Profit Margin. While overall Gross Profit Margin ranking remained unchanged compared to the previous quarter at no. .
Learn about Gross Margin
DRNA's Gross Profit Margin third quarter 2021 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 144
Healthcare Sector # 236
Overall # 794

Gross Profit Margin Statistics
High Average Low
169.5 % 103.66 % 100 %
(Dec 31 2018)   (Sep 30 2021)




Other Gross Profit Margin Profitability Ratios
DRNA's Cumulative Gross Profit Margin
Major Pharmaceutical Preparations Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
DRNA's Gross Profit Margin Profitability versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for DRNA's Competitors
Gross Profit Margin Profit Margin for Dicerna Pharmaceuticals Inc 's Suppliers
Gross Profit Margin Profit Margin for DRNA's Customers

You may also want to know
DRNA's Annual Growth Rates DRNA's Profitability Ratios DRNA's Asset Turnover Ratio DRNA's Dividend Growth
DRNA's Roe DRNA's Valuation Ratios DRNA's Financial Strength Ratios DRNA's Gross Profit Growth
DRNA's Roa DRNA's Inventory Turnover Ratio DRNA's Growth Rates DRNA's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Sep 30 2021, within Major Pharmaceutical Preparations Industry Gross Profit MarginSep 30 2021 MRQ Gross ProfitSep 30 2021 MRQ Revenue




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.